UPDF AI

Fluoroquinolone-Associated Myasthenia Gravis Exacerbation

S. Jones,A. Sorbello,R. Boucher

2011 · DOI: 10.2165/11593110-000000000-00000
Drug Safety · 51 Citations

TLDR

Fluoroquinolone exposure may result in potentially life-threatening myasthenia gravis exacerbations in patients with underlying disease, and healthcare professionals should be aware of this serious drug-disease association.